NCT04391595 LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients Status COMPLETED Phase EARLY_PHASE1
NCT04391062 Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma Status COMPLETED Phase PHASE2
NCT04388033 Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. Status UNKNOWN Phase PHASE1/PHASE2
NCT04359745 Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression Status UNKNOWN Phase N/A
NCT04324840 A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma Status TERMINATED Phase PHASE1
NCT04323046 Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults Status RECRUITING Phase PHASE1
NCT04319276 Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04315584 FDG and FDOPA PET Demonstration of Functional Brain Abnormalities Status UNKNOWN Phase EARLY_PHASE1
NCT04313842 A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED Status UNKNOWN Phase N/A
NCT04280848 Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma Status COMPLETED Phase PHASE2
NCT04270461 NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors Status WITHDRAWN Phase PHASE1
NCT04225039 Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04222309 Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) Status SUSPENDED Phase PHASE1
NCT04219475 Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients Status SUSPENDED Phase N/A
NCT04216329 Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1